Central Trust Company’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,009
Closed -$34K 1164
2016
Q1
$34K Hold
1,009
﹤0.01% 762
2015
Q4
$30K Hold
1,009
﹤0.01% 770
2015
Q3
$32K Buy
+1,009
New +$49.2K ﹤0.01% 719

Other funds holding PGEN

Central Trust Company's PGEN Position: Q2 2016 in Review

Central Trust Company sold out of Precigen (PGEN) in Q2 2016, closing a stake of 1,009 shares — an estimated $34K sold.

Central Trust Company first reported a position in PGEN in Q3 2015 and held it in 3 quarters. The position peaked at $34K in Q1 2016. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Central Trust Company reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Central Trust Company sold 1,009 Precigen shares in Q2 2016, an estimated $34K.
  • Central Trust Company first reported a position in Precigen in Q3 2015 and held it in 3 quarters.
  • Central Trust Company's Precigen position peaked at $34K in Q1 2016.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Central Trust Company's 13F filing for Q2 2016, filed 8 Aug 2016.